Holt, DE, et al.
Neonatal meningitis in England and Wales: 10 years on. Archives of Disease in Childhood – Fetal and Neonatal Edition
2001; 84: F85–F89.
Schuchat, A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clinical Microbiology Reviews
1998; 11: 497–513.
Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. Morbidity and Mortality Weekly Report. Recommendations and Reports
1996; 45: 1–24.
Hansen, SM, et al.
Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. Journal of Clinical Microbiology
2004; 42: 83–89.
Melchers, WJ, et al.
Genetic analysis of Streptococcus agalactiae strains isolated from neonates and their mothers. FEMS Immunology and Medical Microbiology
2003; 36: 111–113.
Tsolia, M, et al.
Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clinical Microbiology and Infection
2003; 9: 832–838.
Schrag, S, et al.
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morbidity and Mortality Weekly Report. Recommendations and Reports
2002; 51: 1–22.
Centers for Disease Control and Prevention. Trends in perinatal group B streptococcal disease – United States, 2000–2006. Morbidity and Mortality Weekly Report
2009; 58: 109–112.
Schrag, SJ, et al.
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New England Journal of Medicine
2000; 342: 15–20.
Verani, JR, et al.
Prevention of perinatal group B streptococcal disease – revised guidelines from CDC, 2010. Morbidity and Mortality Weekly Report. Recommendations and Reports
2010; 59: 1–36.
Sakata, H. Evaluation of intrapartum antibiotic prophylaxis for the prevention of early-onset group B streptococcal infection. Journal of Infection and Chemotherapy
2012; 18: 853–857.
Matsubara, K, Hoshina, K, Suzuki, Y. Early-onset and late-onset group B streptococcal disease in Japan: a nationwide surveillance study, 2004–2010. International Journal of Infectious Diseases. Published online:
. doi: 10.1016/j.ijid.2012.11.027.
Davies, HD, et al.
Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatric Infectious Disease Journal
2001; 20: 879–884.
Edmond, KM, et al.
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet
2012; 379: 547–556.
Persson, E, et al.
Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998–2001. Clinical Microbiology and Infection
2004; 10: 791–796.
Phares, CR, et al.
Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. Journal of the American Medical Association
2008; 299: 2056–2065.
Poyart, C, et al.
Multiplex PCR assay for rapid and accurate capsular typing of B streptococci. Journal of Clinical Microbiology
2007; 45: 1985–1988.
Yao, K, et al.
Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. Journal of Clinical Microbiology
2013; 51: 503–507.
Jones, N, et al.
Multilocus sequence typing system for group B streptococcus. Journal of Clinical Microbiology
2003; 41: 2530–2536.
Davies, HD, et al.
Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. Journal of Infectious Diseases
2004; 189: 1097–1102.
Lamy, MC, et al.
Rapid detection of the ‘highly virulent’ group B streptococcus ST-17 clone. Microbes and Infection
2006; 8: 1714–1722.
Lin, FY, et al.
Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. Journal of Clinical Microbiology
2006; 44: 1257–1261.
Martins, ER, et al.
Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. Journal of Clinical Microbiology
2007; 45: 3224–3229.
Igarashi, Y, Mitsuhashi, N. Detection of Streptococcus agalactiae (GBS) and capsular types in prenatal vaginal specimens by real-time PCR as part of a neonatal GBS prevention strategy. Juntendo Medical Journal
2012; 58: 218–223.
Wajima, T, et al.
Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease. Journal of Medical Microbiology
2008; 57: 1383–1388.
Japan Society of Obstetrics and Gynecology (JSOG). Guidelines for obstetrical practice in Japan 2008 [in Japanese].
Shinjoh, M, et al.
2012. Childhood bacterial meningitis trends in Japan from 2009 to 2010 [in Japanese]. Kansenshogaku Zasshi
Sunakawa, K, et al.
2010. Childhood bacterial meningitis trends in Japan from 2007 to 2008 [in Japanese]. Kansenshogaku Zasshi
Japan Society of Obstetrics and Gynecology (JSOG). Guidelines for obstetrical practice in Japan 2011 [in Japanese].
Poyart, C, et al.
Invasive group B streptococcal infections in infants, France. Emerging Infectious Diseases journal
2008; 14: 1647–1649.
Milligan, TW, et al.
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infection and Immunity
1978; 21: 738–746.
Adderson, EE, et al.
Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae
. Infection and Immunity
2003; 71: 6857–6863.
Schubert, A, et al.
The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infection and Immunity
2004; 72: 6197–6205.
Maisey, HC, et al.
Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. Journal of Bacteriology
2007; 189: 1464–1467.
Bryan, JD, Shelver, DW.
Streptococcus agalactiae CspA is a serine protease that inactivates chemokines. Journal of Bacteriology
2009; 191: 1847–1854.
Gherardi, G, et al.
Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. Journal of Clinical Microbiology
2007; 45: 2909–2916.
Martins, ER, et al.
Group B streptococci causing neonatal infections in Barcelona are a stable clonal population: 18-year surveillance. Journal of Clinical Microbiology. 2011; 49: 2911–2918.
Al, Safadi R, et al.
Two-component system RgfA/C activates the fbsB gene encoding major fibrinogen-binding protein in highly virulent CC17 clone group B Streptococcus. PLoS One
2011; 6: e14658.
Seifert, KN, et al.
A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae
2006; 152: 1029–1040.
Springman, AC, et al.
Selection, recombination, and virulence gene diversity among group B streptococcal genotypes. Journal of Bacteriology
2009; 191: 5419–5427
Sørensen, UB, et al.
Emergence and global dissemination of host-specific Streptococcus agalactiae clones. MBio
2010; 1: e00178–10.
Kimura, K, et al.
First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrobial Agents and Chemotherapy
2008; 52: 2890–2897.
Dahesh, S, et al.
Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy
2008; 52: 2915–2918.